Cannabis Americas Common Sense Crops
Thirty-two states have legalized medical marijuana in some form or another. With the help of some reform-minded activists and the general public, are our politicians starting to come to their senses on cannabis?
Landmark study reveals gas stove emissions boost childhood asthma rates, adult deaths
The study, published Friday in Science Advances, represents the first time researchers have quantified the link between gas stoves and asthma from NO2 exposures inside homes.
Progressive Briefing for Tuesday, July 31, 2018
Worker's wages fall, Federal judge orders government to seek consent before medicating migrant children, Bernie Sanders thanks the Koch brothers, and more.
To regain people’s trust, the Democratic Party must support single-payer
Nearly 60 percent of Americans want Medicare for All. Democrats must support it, too.
Air Pollution is Creating a “Public Health Emergency”
Air pollution is increasing at an alarming rate and needs to be made a priority for public safety.
Pandemic doesn’t stop corporate media from crusading against universal healthcare
It’s clear that the American system of making health insurance a privilege only for those who work—or for those poor and old enough to qualify for Medicaid and Medicare—has made the U.S. especially vulnerable to Covid-19.
How Mexican farmers got the better of Trump
Turns out corn farmers south of the border know more about trade than the U.S. president.
FDA Changes Food Nutrition Label Requirements for the First Time in 20 Years
Michelle Obama helped to announce on Friday that the FDA approved a new set of requirements for food nutrition labels for the first time in decades.
Internal EPA documents show scramble for data on Monsanto’s Roundup
Monsanto itself has admitted a lack of extensive safety tests on its formulated products.
Trump tax cuts helped health giants dodge billions while patients faced higher costs and...
New report finds seven major healthcare corporations avoided over $34 billion in taxes since 2017 while boosting buybacks, dividends, and executive pay as claim denials and patient safety issues escalated.